Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

v3.20.4
Accrued Expenses and Other Current Liabilities
12 Months Ended
Dec. 31, 2020
Accrued Expenses and Other Current Liabilities  
Accrued Expenses and Other Current Liabilities

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

December 31, 

    

2020

    

2019

Compensation and benefits

$

2,919

$

1,786

Commercial expenses

605

Legal expenses

784

86

Pharmaceutical development expenses

 

413

 

445

Accrued interest

 

 

18

Other accrued expenses and other current liabilities

 

447

 

68

Total accrued expenses and other current liabilities

$

5,168

$

2,403